Resources
Ten Mistakes to Avoid when Searching Gene Sequences
Avoid the costly pitfalls of inaccurate, irrelevant, and untimely search results - what you need to consider before your next search.
Learn More»
The value of a cost-effective informatics platform that enables rapid and relevant search of the vast universe of sequences and their patents with regard to commercialization of new drugs cannot be understated. This is particularly true in the fast-paced R&D area of infectious disease research. We selected GenomeQuest™ for its ability to instantly locate sequence data and display it in an intuitive and easily manipulated format.
Director of Research (Anti-Infectives) and Manager, Intellectual Property
GenomeQuest, Inc. Announces Collaboration with Servier to Improve Specificity of Microarray Probes and qPCR Results
Tuesday, May 1st, 2007
Leader in sequence search partners with leading French independent pharmaceutical company to more effectively leverage in-house data sources.
Westborough, Massachusetts - May 1, 2007 — GenomeQuest, Inc. a leader in sequence search for research and IP, today announced a collaboration with Servier, the leading French independent pharmaceutical company, to seamlessly connect results from high-throughput microarray experiments to qPCR platforms from different vendors, including Servier proprietary reagent data sets.
As part of the collaboration, Servier provided key scientific insights and guidance to form product requirements while GenomeQuest, Inc. leveraged its many years of expertise in bioinformatics, high-performance computing, and data management. The collaboration produced a system that optimizes experimental study design and analysis by providing a simple way to view and analyze the exhaustive set of transcripts and biological assays for a gene. The deliverables of the collaboration to Servier include highly maintainable gene catalogs for human, mouse, and rat and a companion visualization module that integrates all Servier proprietary content with public and vendor reagent libraries. In turn, GenomeQuest, Inc. has retained the right to commercialize the software and know-how to help other companies with a similar requirement integrate their own proprietary data sets.
Emmanuel Canet, M.D. Ph.D, Vice President of Research and Development of Servier, said, "We chose to work with GenomeQuest, Inc. because we have a long track record of successful innovations working with Jean-Jacques Codani PhD. and his team on a range of bioinformatics projects over many years. More importantly, we could see that GenomeQuest, Inc. management had a vision for how to commercialize the results of our collaboration. This set the stage for a true win-win partnership. Servier gains early access to the technology and GenomeQuest is able to leverage the investment for the long-term."
Ronald Ranauro, President and CEO of GenomeQuest, Inc., said, "It is GenomeQuest's privilege to work closely with Servier and gain access to their scientific team to leverage their scientific insights into our long-term product strategy."
About Servier
Servier is the leading independent French pharmaceutical company, established in 1954 by its founder, Jacques Servier, M.D., Pharm.D. The group is established in 140 countries and 82% of Servier products are prescribed out of France. Sales turnover in 2006 rose to 3.3 billion euros. Almost 25% of Servier's turnover is invested in research and development. The Servier Group counts 16 International Centers of Therapeutic Research, and its principal therapeutic research orientations are cardiovascular diseases, diabetes, neuropsychiatric disorders, cancer, and osteoarticular diseases. More information is available at: www.servier.com.
About GenomeQuest, Inc.
GenomeQuest, Inc. is a leader in biological sequence search, content and analysis. Backed by an automatically-updated database that includes over 137 million sequence records, the company's flagship product, GenomeQuest™ 4.0, is a Web-based search and analysis application that provides scientists and IP professionals with one source for the most comprehensive, accurate and complete sequence information available. Leading life sciences companies and IP law firms rely on GenomeQuest 4.0 to help drive key scientific research and business decisions.
GenomeQuest, Inc., is headquartered in Westborough, Massachusetts. For more information, call (508) 616-0100, or visit www.genomequest.com.